Works matching DE "OTSUKA Pharmaceutical Europe Ltd."

OTSUKA PHARMACEUTICAL EUROPE LTD WITHDRAWS ITS APPLICATION FOR AN EXTENSION OF INDICATION FOR ABILIFY (ARIPIPRAZOLE).

Published in:

Psychiatry (1550-5952), 2009, v. 6, n. 11, p. 9

Publication type:

Article